Comment
doi: 10.1016/j.ijcard.2017.06.021.
Reply to Letter to the Editor entitled: "Bioresorbable stent thrombosis, lactic acid release and Kounis syndrome"
Affiliations
- PMID: 28916056
- DOI: 10.1016/j.ijcard.2017.06.021
Item in Clipboard
Comment
Reply to Letter to the Editor entitled: "Bioresorbable stent thrombosis, lactic acid release and Kounis syndrome"
Int J Cardiol.
.
No abstract available
Keywords: BVS; Biodegradable scaffold; Bioresorbable vascular scaffold; Drug-eluting stent; Magnesium stent; Scaffold thrombosis; Stent thrombosis; Thrombogenicity.
Comment on
-
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year follow-up: A systematic review and meta-analysis of studies.Int J Cardiol. 2016 Oct 15;221:1087-94. doi: 10.1016/j.ijcard.2016.07.101. Epub 2016 Jul 9. Int J Cardiol. 2016. PMID: 27448538
-
Bioresorbable stent thrombosis, lactic acid release and Kounis syndrome.Int J Cardiol. 2017 Nov 15;247:15. doi: 10.1016/j.ijcard.2017.05.131. Int J Cardiol. 2017. PMID: 28916055 No abstract available.
Similar articles
-
Bioresorbable stent thrombosis, lactic acid release and Kounis syndrome.Int J Cardiol. 2017 Nov 15;247:15. doi: 10.1016/j.ijcard.2017.05.131. Int J Cardiol. 2017. PMID: 28916055 No abstract available.
-
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-197. doi: 10.1016/j.jcin.2014.10.005. JACC Cardiovasc Interv. 2015. PMID: 25616924
-
Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial.Int J Cardiol. 2017 Sep 15;243:121-125. doi: 10.1016/j.ijcard.2017.05.053. Epub 2017 May 12. Int J Cardiol. 2017. PMID: 28576627 Clinical Trial.
-
Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: from bench to clinical use.Expert Rev Cardiovasc Ther. 2015 Oct;13(10):1127-45. doi: 10.1586/14779072.2015.1089172. Expert Rev Cardiovasc Ther. 2015. PMID: 26401921 Review.
-
Performance of bioresorbable vascular scaffolds versus cobalt-chromium everolimus-eluting stent in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a review of currently available clinical data.Minerva Cardioangiol. 2016 Feb;64(1):74-83. Epub 2015 Oct 8. Minerva Cardioangiol. 2016. PMID: 26447989 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
